Stay updated on Nivolumab with Chemoradiation in NPC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with Chemoradiation in NPC Clinical Trial page.

Latest updates to the Nivolumab with Chemoradiation in NPC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be a minor update with no impact on study details or user-facing functionality.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this is a minor maintenance change that does not affect study content or usability, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedShow glossary added to the page interface. UI/text changes include the label update 'Last Update Submitted that Met QC Criteria', capitalization tweaks for 'No FEAR Act Data', and revision number updated from v3.3.4 to v3.4.0; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedResults section updated to include posted outcomes (ORR, AEs, LRC, DM, FACT-NP) and biomarker analyses, along with 'Results First Posted' and related QC dates on 2026-01-12.SummaryDifference2%

- Check63 days agoChange DetectedA new Locations section is added with California listed as a site, clarifying the study locations. The prior 'California Locations' entry is removed as part of a reorganization of the location information.SummaryDifference0.2%

- Check92 days agoChange DetectedSite revision label updated from v3.2.0 to v3.3.2. No substantive changes to the study details, eligibility criteria, or other user-facing content.SummaryDifference0.1%

Stay in the know with updates to Nivolumab with Chemoradiation in NPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with Chemoradiation in NPC Clinical Trial page.